Pacira BioSciences, Inc. (NASDAQ: PCRX) related to its sale to Viatris Inc. Under the terms of the proposed transaction, Pacira shareholders are expected to receive $36.50 in cash per share.
Pacira BioSciences, Inc. (NASDAQ: PCRX) related to its sale to Viatris Inc. Under the terms of the proposed transaction, Pacira shareholders are expected to receive $36.50 in cash per share.